Key result
Berberine use is linked to severe QTc prolongation and reversible polymorphic ventricular tachycardia.
Why the study?
Berberine is widely used for cardiometabolic benefits but may cause electrophysiologic changes leading to life-threatening arrhythmias, which are under-recognized.
Does berberine exposure increase the risk of severe QTc prolongation and polymorphic ventricular tachycardia in elderly patients?
Case Report (n=1)
No
Does berberine exposure increase the risk of severe QTc prolongation and polymorphic ventricular tachycardia in elderly patients?
Over-the-counter berberine supplementation can induce dangerous electrophysiologic changes, specifically bradycardia and severe QTc prolongation leading to life-threatening torsades de pointes.
Answers are grounded in this paper and cite their sources.
Berberine may trigger torsades in elderly patients; this case leaves open the need for prospective safety studies.
INTRODUCTION: Natural supplements are readily available without a prescription and are not regulated by the United States Food and Drug Administration. The popularity of berberine, a bioactive compound used for centuries in traditional Chinese medicine, has surged due to its proposed benefits in glycemic control and cardiovascular health. However, use of berberine may lead to possible negative electrophysiologic changes. CASE REPORT: A 92-year-old male presented to the emergency department (ED) with chief complaints of tremors, urinary incontinence, and brief syncopal episodes that began approximately two weeks after starting berberine. In the ED he had multiple episodes of polymorphic ventricular tachycardia with pulselessness requiring immediate cardioversion, with a rapid return of spontaneous circulation between episodes. Amiodarone was started; however, despite this, he continued to have persistent episodes. Finally, the episodes resolved after starting lidocaine and isoproterenol in the intensive care unit. The patient's workup was notable for heart rate-corrected QT interval (QTc) prolongation (QTc 616 milliseconds (ms) [male reference range, QTc < 430 ms]) confirming the polymorphic ventricular tachycardia as torsades de pointes. His cardiac evaluation was otherwise normal, including a normal ejection fraction on a transthoracic echocardiogram. Withholding berberine and supportive management resulted in an improved QTc. On hospital day 3, the QTc was 454 ms. The patient had a short inpatient admission and was discharged without any further episodes. CONCLUSION: Berberine has numerous effects and is purported to have beneficial effects and cardioprotective properties. Due to induced bradycardia and QT prolongation, patients who take berberine can be vulnerable to life-threatening arrhythmias, such as the R-on-T phenomenon in our patient's case. Additional research on berberine is needed to better inform clinician-patient discussions about its use.
No takes yet. Share an insight, caveat, or question.
Mesmin et al. (2026) conducted a case report in Polymorphic ventricular tachycardia and QTc prolongation (n=1). Berberine was evaluated on Resolution of ventricular tachycardia and improvement of QTc interval. Berberine use in a 92-year-old man resulted in severe QTc prolongation (616 ms) and recurrent pulseless polymorphic ventricular tachycardia, which resolved after discontinuation of the supplement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: